Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa) Meeting Abstract


Authors: McBride, S. M.; Zelefsky, M. J.; Spratt, D. E.; Kollmeier, M.; Slovin, S. F.; Aghalar, J.; Hearn, J. W.; Den, R. B.; Deville, C.; Borofsky, K.; Xiao, H.; Abida, W.; Scher, H. I.; Rathkopf, D. E.
Abstract Title: Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 292s
Language: English
ACCESSION: WOS:000442916007675
DOI: 10.1200/JCO.2018.36.15_suppl.TPS5100
PROVIDER: wos
Notes: Meeting Abstract: TPS5100 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael J Zelefsky
    755 Zelefsky
  2. Han Xiao
    61 Xiao
  3. Susan Slovin
    254 Slovin
  4. Marisa A Kollmeier
    229 Kollmeier
  5. Dana Elizabeth Rathkopf
    275 Rathkopf
  6. Howard Scher
    1131 Scher
  7. Wassim Abida
    158 Abida
  8. Daniel Eidelberg Spratt
    77 Spratt
  9. Sean Matthew McBride
    301 McBride